InvestorsHub Logo

StevenRisk

04/23/17 8:11 AM

#29568 RE: HankyFrank #29567

I bet same-lab SGBY revenues will only be marginally higher in Q2.

Tend to agree.Don't forget the $130K on receivables. Overall I do agree with you and appreciate your posts as they are not rah rah rah but well thought out.

Magnum7419

04/23/17 10:25 AM

#29572 RE: HankyFrank #29567

At this time, it is a guessing game on revenue regarding how much and when the testing occurs,harvest times etc. Since testing started in Oct and Nov numbers were so huge I thought feb or march numbers would be greater based on testing that occured in the previous 60 days .

Till we learn more, I as a shareholder am satisfied with the progress and expect the share price to increase as the company continues to expand.

What I appreciate is the fact that the price has stabilized at .02 for several months and is not volatile like other penny stocks.

The audit issue has apparently put expansion on hold and now we should hear more about the California growth plan.


Weekly sales jumping from 1.5 to 7 million in Oregon did get me excited
as I watch this story unfold .

If those numbers are possible in Oregon , imagine the numbers California will create now that mandatory independent testing is required.

My hunch was right last summer when I entered this stock and chapter one of this book is not finished yet IMHO.

Enjoy the ride